Van Plew Daniel P
SEC CIK 1411984 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals | EVP, General Mgr, Industrial | 21.7K | — | $45.81M | 36 | 2021-08-09 | 2025-12-09 |
Most active insiders at REGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | POON CHRISTINE A | Dir | — | $4.25M |
| 2 | McCourt Marion | EVP Commercial | — | $2.00M |
| 3 | Zoghbi Huda Y | Dir | — | $1.92M |
| 4 | Pitofsky Jason | VP Ctrl | — | $1.87M |
| 5 | Bassler Bonnie L | Dir | — | $1.77M |
| 6 | Guarini Kathryn | Dir | — | $660.0K |
| 7 | RYAN ARTHUR F | Dir | — | $434.7K |
| 8 | MURPHY ANDREW J | EVP Research | — | — |
| 9 | Fenimore Christopher R. | EVP Fin CFO | — | — |
| 10 | Schenkein David P | Dir | — | — |
| 12 | Van Plew Daniel P | EVP, General Mgr, Industrial | — | — |
Transactions 36
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-11 | 2025-12-09 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $701.51 | -2,552 | 21.7K | -11% | -$1.79M | |
| D | 2025-12-09 | 2025-12-05 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | A - Grant | $0.00 | +3,715 | 26.1K | +17% | $0 |
| D | 2025-12-09 | 2025-12-08 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $712.94 | -1,906 | 24.2K | -7% | -$1.36M |
| 2024-12-18 | 2024-12-16 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $730.81 | -969 | 34.8K | -3% | -$708.2K | |
| D | 2024-12-10 | 2024-12-06 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | A - Grant | $0.00 | +3,499 | 36.3K | +11% | $0 |
| D | 2024-12-10 | 2024-12-09 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $787.00 | -492 | 35.8K | -1% | -$387.2K |
| M | 2024-02-16 | 2024-02-14 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | S - Sale | $942.28 | -10.4K | 21.6K | -33% | -$9.83M |
| DM | 2024-02-13 | 2024-02-09 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $378.30 | +35.4K | 32.6K | New | +$13.38M |
| DM | 2024-02-13 | 2024-02-09 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $951.68 | -24.9K | 24.0K | -51% | -$23.74M |
| D | 2023-12-12 | 2023-12-08 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | A - Grant | $0.00 | +3,199 | 23.6K | +16% | $0 |
| DM | 2023-12-12 | 2023-12-08+ | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $844.01 | -4,329 | 20.4K | -18% | -$3.65M |
| DM | 2023-08-25 | 2023-08-24 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | S - Sale+OE | $841.71 | -6,197 | 27.6K | -18% | -$5.22M |
| D | 2023-08-25 | 2023-08-23 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $381.40 | +23.1K | 44.6K | +108% | +$8.82M |
| D | 2023-08-25 | 2023-08-23 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $842.66 | -16.9K | 27.7K | -38% | -$14.26M |
| D | 2022-12-20 | 2022-12-16 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | A - Grant | $0.00 | +3,798 | 33.9K | +13% | $0 |
| 2022-12-13 | 2022-12-09 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $753.28 | -492 | 30.1K | -2% | -$370.6K | |
| D | 2022-11-25 | 2022-11-22 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $378.98 | +50.0K | 80.6K | +164% | +$18.95M |
| DM | 2022-11-25 | 2022-11-23 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | S - Sale+OE | $740.75 | -12.0K | 30.6K | -28% | -$8.87M |
| D | 2022-11-25 | 2022-11-22 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $741.81 | -38.0K | 42.5K | -47% | -$28.21M |
| DM | 2022-11-08 | 2022-11-07 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | S - Sale+OE | $745.40 | -7,886 | 31.0K | -20% | -$5.88M |
| D | 2022-11-08 | 2022-11-04 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $381.92 | +34.0K | 64.6K | +111% | +$12.99M |
| D | 2022-11-08 | 2022-11-04 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $725.84 | -26.1K | 38.5K | -40% | -$18.95M |
| DM | 2022-09-13 | 2022-09-12 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | S - Sale+OE | $716.38 | -4,696 | 32.3K | -13% | -$3.36M |
| D | 2022-09-13 | 2022-09-09 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $555.67 | +40.0K | 70.6K | +131% | +$22.23M |
| D | 2022-09-13 | 2022-09-09 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $730.96 | -35.3K | 35.3K | -50% | -$25.81M |
| DM | 2022-02-24 | 2022-02-23 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | S - Sale+OE | $613.99 | -6,781 | 35.8K | -16% | -$4.16M |
| D | 2022-02-24 | 2022-02-22 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $399.66 | +40.0K | 70.6K | +131% | +$15.99M |
| D | 2022-02-24 | 2022-02-22 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $610.56 | -33.2K | 37.4K | -47% | -$20.28M |
| 2021-12-14 | 2021-12-11 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $664.34 | -697 | 30.6K | -2% | -$463.0K | |
| D | 2021-12-10 | 2021-12-08 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | A - Grant | $0.00 | +4,344 | 31.3K | +16% | $0 |
| D | 2021-11-17 | 2021-11-15 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $270.43 | +25.0K | 51.9K | +93% | +$6.76M |
| D | 2021-11-17 | 2021-11-15 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $641.50 | -18.2K | 33.7K | -35% | -$11.69M |
| DM | 2021-11-17 | 2021-11-16 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | S - Sale+OE | $656.86 | -6,778 | 30.7K | -18% | -$4.45M |
| DM | 2021-08-10 | 2021-08-10 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | S - Sale+OE | $611.86 | -6,603 | 31.1K | -17% | -$4.04M |
| D | 2021-08-10 | 2021-08-09 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $617.68 | -18.4K | 33.5K | -35% | -$11.36M |
| D | 2021-08-10 | 2021-08-09 | REGN | Regeneron Pharmaceuticals | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $270.43 | +25.0K | 51.9K | +93% | +$6.76M |
Purchase Sale Sale after option exercise All abbreviations